Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

MET variant as a prognostic marker in clear cell renal cell carcinoma

Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA

MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC

Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )

Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant...

Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr...

Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer ( Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr John Fitzpatrick )

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )

mCRPC: Challenges and opportunities in a booming area

Dr Nicolas Mottet - University Hospital, Saint-Étienne, France

mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK

Managing mCRPC in daily practice: a pragmatic approach ( Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK )

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel...

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast...

Dr Barbara Fowble - University of California, San Francisco, USA

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer ( Dr Barbara Fowble - University of California, San Francisco, USA )

Improving outcomes in chronic lymphocytic leukaemia

Prof John Gribben - Queen Mary University of London, UK and Prof Barbara...

Improving outcomes in chronic lymphocytic leukaemia ( Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany )

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA

Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )

New therapy aspects for myeloid chronic lymphoma

Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine

New therapy aspects for myeloid chronic lymphoma ( Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine )

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for...

Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille...

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )

More from ecancer